Lasa Supergenerics P/B Ratio
Lasa Supergenerics (LASA) P/B ratio is 0.67 (Low), book value per share ₹16.80 — Low - Trading below book value, may indicate undervaluation. For live price, earnings yield and the full fundamental profile, see Lasa Supergenerics stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
LASA P/B Ratio — Valuation Insights & Book Value Analysis
Lasa Supergenerics price-to-book ratio interpretation, valuation status and historical context — current P/B 0.67 (Low). Read Lasa Supergenerics dividend policy for the complete payout history and dividend yield track record.
- Stock appears undervalued with PB of 0.67, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 44.2% below historical average
- Trading at premium to sector average PB of -0.0
Lasa Supergenerics P/B Ratio Historical Trend
LASA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore LASA fundamental worth to estimate fundamental worth using multiple valuation models.
LASA Historical P/B Ratio — Book Value Per Share & Year-End Price
Lasa Supergenerics annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.56 | ₹16.8 | ₹9.44 | ₹84 | Low |
| 2024 | 1.33 | ₹19.4 | ₹25.84 | ₹97 | Moderate |
| 2023 | 1.27 | ₹23.6 | ₹29.96 | ₹118 | Moderate |
| 2022 | 1.06 | ₹31.6 | ₹33.60 | ₹158 | Moderate |
| 2021 | 1.78 | ₹38.78 | ₹68.85 | ₹159 | Moderate |
LASA vs Healthcare Peers — P/B Ratio Comparison
Lasa Supergenerics P/B 0.67 vs Healthcare average -0.0, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |